Skip to main content Skip to section navigation Skip to footer
CohBar, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Programs & Pipelines
    • Overview
    • Our Approach
    • CB5138-3
    • CB4211
    • CB5064 Analogs
    • Posters & White Papers
  • Patient Resources
    • Overview
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Partners
  • Careers
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
May 13, 2016 9:05am EDT

CohBar, Inc. Announces First Quarter 2016 Financial Results

Apr 11, 2016 3:00pm EDT

CohBar, Inc. Announces Preclinical Proof-of-principle Publication for SHLP Mitochondrial-derived Peptides and their Role in Metabolic Regulation and Cell Viability

Mar 09, 2016 4:05pm EST

CohBar, Inc. Announces Fourth Quarter 2015 Financial Results

Mar 08, 2016 9:00am EST

CohBar, Inc. Appoints Simon Allen as Chief Executive Officer

Feb 24, 2016 11:37am EST

CohBar, Inc. to Announce 2015 Fourth Quarter Financial Results and Host Conference Call for Shareholders on March 9, 2016

Feb 03, 2016 4:15pm EST

CohBar, Inc. Engages Torrey Hills Capital

Jan 07, 2016 4:15pm EST

CohBar, Inc. Engages Torrey Hills Capital

Nov 16, 2015 4:05pm EST

CohBar, Inc. Announces Third Quarter 2015 Financial Results

Nov 11, 2015 4:58pm EST

CohBar, Inc. To Announce 2015 Third Quarter Financial Results and Host Conference Call for Shareholders on November 16, 2015

Oct 06, 2015 3:00pm EDT

CohBar, Inc. Presentation Now Available for On-Demand Viewing

  • arrow_back
  • 1…
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • arrow_forward
©2022 CohBar, Inc. All Rights Reserved.
Privacy Policy Sitemap Terms of Use